FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283826265> ?p ?o ?g. }

• W4283826265 endingPage "274" @default.
• W4283826265 startingPage "268" @default.
• W4283826265 abstract "Hepatorenal syndrome (HRS) is the most severe form of acute kidney injury in patients with advanced cirrhosis, and it is associated with high mortality. It is usually diagnosed according to criteria defined by the International Ascites Club. Currently, the most frequently indicated pharmacological therapy for the treatment of HRS is a combination of splanchnic vasoconstrictors (terlipressin or norepinephrine) in combination with albumin. With the progressive increase in healthcare spending, it is important to conduct a cost-effectiveness analysis of pharmacological treatment in patients who are diagnosed with HRS.To perform a cost-effectiveness assessment for the use of terlipressin in combination with albumin to treat HRS in patients with cirrhosis.Economic evaluation of cost-effectiveness based on secondary data from studies showed the efficacy of terlipressin therapy compared with norepinephrine combined with albumin or albumin alone. The cost-effectiveness analysis was calculated using an incremental cost-effectiveness ratio (ICER), and a sensitivity analysis was developed by varying the values of therapies and probabilities. The Brazilian real was the currency used in the analysis, and the results were converted to US dollars.After selection, eligibility, and evaluation of the quality of publications, the results demonstrated that administration of terlipressin or norepinephrine in combination with albumin in patients diagnosed with HRS type 1 was efficacious. The cost of treatment with terlipressin in combination with albumin was USD $1,644.06, administration of albumin alone was USD $912.02, and norepinephrine plus albumin was USD $2,310.78. Considering that the combination therapies demonstrated effectiveness, the incremental cost of terlipressin and norepinephrine in combination with albumin was USD $666.73, and an effectiveness of 0.570 was found for terlipressin in combination with albumin and 0.200 for norepinephrine in combination with albumin. The incremental effectiveness was 0.370, and the ICER was USD $1,801.97. Thus, the parameters of increasing cost per therapy and ICER indicated that the combined therapy of terlipressin plus albumin was cost effective compared to albumin alone or norepinephrine plus albumin in a public single-payer healthcare system.A cost-effectiveness analysis showed that terlipressin in combination with albumin when administered concomitantly to patients who were diagnosed with type 1 HRS is cost-effective compared to norepinephrine in combination with albumin administered in a controlled environment." @default.
• W4283826265 created "2022-07-07" @default.
• W4283826265 creator A5005971805 @default.
• W4283826265 creator A5035252668 @default.
• W4283826265 creator A5049534256 @default.
• W4283826265 creator A5058826602 @default.
• W4283826265 creator A5066461132 @default.
• W4283826265 date "2022-06-01" @default.
• W4283826265 modified "2023-09-26" @default.
• W4283826265 title "COST EFFECTIVENESS OF USING TERLIPRESSIN TO TREAT HEPATORENAL SYNDROME" @default.
• W4283826265 cites W1967589221 @default.
• W4283826265 cites W1975587900 @default.
• W4283826265 cites W1977356230 @default.
• W4283826265 cites W2021578867 @default.
• W4283826265 cites W2036652612 @default.
• W4283826265 cites W2052732693 @default.
• W4283826265 cites W2094598763 @default.
• W4283826265 cites W2131820725 @default.
• W4283826265 cites W2131903288 @default.
• W4283826265 cites W2164601307 @default.
• W4283826265 cites W2282617728 @default.
• W4283826265 cites W2317935894 @default.
• W4283826265 cites W2411238136 @default.
• W4283826265 cites W2557658892 @default.
• W4283826265 cites W2895004242 @default.
• W4283826265 cites W2959887800 @default.
• W4283826265 cites W2967735266 @default.
• W4283826265 cites W2978744416 @default.
• W4283826265 cites W3028499124 @default.
• W4283826265 cites W3159795713 @default.
• W4283826265 cites W3189287384 @default.
• W4283826265 cites W4211060913 @default.
• W4283826265 cites W4230979353 @default.
• W4283826265 cites W4246676001 @default.
• W4283826265 cites W80909407 @default.
• W4283826265 doi "https://doi.org/10.1590/s0004-2803.202202000-48" @default.
• W4283826265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35830040" @default.
• W4283826265 hasPublicationYear "2022" @default.
• W4283826265 type Work @default.
• W4283826265 citedByCount "1" @default.
• W4283826265 countsByYear W42838262652023 @default.
• W4283826265 crossrefType "journal-article" @default.
• W4283826265 hasAuthorship W4283826265A5005971805 @default.
• W4283826265 hasAuthorship W4283826265A5035252668 @default.
• W4283826265 hasAuthorship W4283826265A5049534256 @default.
• W4283826265 hasAuthorship W4283826265A5058826602 @default.
• W4283826265 hasAuthorship W4283826265A5066461132 @default.
• W4283826265 hasBestOaLocation W42838262651 @default.
• W4283826265 hasConcept C126322002 @default.
• W4283826265 hasConcept C177713679 @default.
• W4283826265 hasConcept C2776125364 @default.
• W4283826265 hasConcept C2776988256 @default.
• W4283826265 hasConcept C2777214474 @default.
• W4283826265 hasConcept C2779393834 @default.
• W4283826265 hasConcept C2780496750 @default.
• W4283826265 hasConcept C71924100 @default.
• W4283826265 hasConceptScore W4283826265C126322002 @default.
• W4283826265 hasConceptScore W4283826265C177713679 @default.
• W4283826265 hasConceptScore W4283826265C2776125364 @default.
• W4283826265 hasConceptScore W4283826265C2776988256 @default.
• W4283826265 hasConceptScore W4283826265C2777214474 @default.
• W4283826265 hasConceptScore W4283826265C2779393834 @default.
• W4283826265 hasConceptScore W4283826265C2780496750 @default.
• W4283826265 hasConceptScore W4283826265C71924100 @default.
• W4283826265 hasIssue "2" @default.
• W4283826265 hasLocation W42838262651 @default.
• W4283826265 hasLocation W42838262652 @default.
• W4283826265 hasOpenAccess W4283826265 @default.
• W4283826265 hasPrimaryLocation W42838262651 @default.
• W4283826265 hasRelatedWork W2029697393 @default.
• W4283826265 hasRelatedWork W2063134252 @default.
• W4283826265 hasRelatedWork W2183194993 @default.
• W4283826265 hasRelatedWork W2338756788 @default.
• W4283826265 hasRelatedWork W2405781721 @default.
• W4283826265 hasRelatedWork W2443331516 @default.
• W4283826265 hasRelatedWork W3009993021 @default.
• W4283826265 hasRelatedWork W3028957297 @default.
• W4283826265 hasRelatedWork W3213303112 @default.
• W4283826265 hasRelatedWork W90121162 @default.
• W4283826265 hasVolume "59" @default.
• W4283826265 isParatext "false" @default.
• W4283826265 isRetracted "false" @default.
• W4283826265 workType "article" @default.